Introduction
The drug identified by the National Drug Code (NDC) 24658-0270 is Cholestyramine Light, manufactured by PuraCap Laboratories LLC, which operates under the name Blu Pharmaceuticals. Here, we will delve into the market analysis and price projections for this specific drug.
Drug Overview
Cholestyramine Light is a bile acid sequestrant used primarily to lower cholesterol levels and treat certain types of pruritus (itching) associated with liver disease. It works by binding to bile acids in the intestine, which helps reduce the amount of cholesterol produced in the liver[1].
Market Dynamics
Demand and Supply
The demand for cholesterol-lowering medications remains steady due to the prevalence of hypercholesterolemia and other cardiovascular diseases. Cholestyramine Light, being a generic medication, benefits from a stable demand as it is often prescribed as a cost-effective alternative to brand-name drugs.
Competition
The market for bile acid sequestrants is relatively niche but competitive. Cholestyramine Light competes with other generic and brand-name bile acid sequestrants. However, its generic status and the reputation of the manufacturer can influence its market share.
Regulatory Environment
Regulatory changes, such as those proposed by the FDA regarding the National Drug Code format, do not directly impact the pricing of Cholestyramine Light but can affect the overall efficiency and transparency of the pharmaceutical supply chain[4].
Pricing Trends
Historical Pricing
Pricing trends for generic drugs like Cholestyramine Light can be volatile. The Oregon Drug Price Transparency Program report highlights significant price increases in generic drugs, with some examples showing increases of up to 2,527% over a decade. However, such drastic increases are not typical for all generic drugs[2].
Current Pricing
As of the latest available data, the pricing for Cholestyramine Light is influenced by various factors including production costs, market competition, and regulatory oversight. The Wholesale Acquisition Cost (WAC) for such medications can fluctuate based on these factors.
Price Projections
Given the current market dynamics, here are some key points to consider for price projections:
Generic Drug Price Increases
The median price increase for generic drugs has been around 19.9%, according to the Oregon report. While this is a general trend, the actual price increase for Cholestyramine Light could vary based on specific market conditions and the strategies of PuraCap Laboratories LLC[2].
Regulatory Impact
Efforts to enhance transparency and control costs, such as the implementation of upper payment limits or increased regulatory oversight, could stabilize or reduce price increases for generic drugs like Cholestyramine Light[2].
Market Competition
The competitive landscape will continue to influence pricing. If other manufacturers enter the market with similar products, it could lead to price competition and potentially lower prices for Cholestyramine Light.
Consumer and Payer Impact
Consumer Access
Price increases can significantly affect consumer access to medications. High price increases, even for generic drugs, can lead to affordability issues for patients, especially those without comprehensive health insurance.
Payer Perspective
Health insurers and pharmacy benefit managers (PBMs) are closely monitoring drug prices due to their impact on healthcare costs. Any significant price changes for Cholestyramine Light would be scrutinized by these entities to ensure they do not disproportionately increase healthcare expenditures[2].
Conclusion
The market analysis for Cholestyramine Light (NDC: 24658-0270) indicates a stable demand driven by the need for cholesterol-lowering medications. However, pricing trends are subject to various factors including competition, regulatory changes, and overall market dynamics.
Key Takeaways
- Stable Demand: Cholestyramine Light benefits from a steady demand due to its use in treating hypercholesterolemia.
- Competitive Market: The generic drug market is competitive, which can influence pricing.
- Regulatory Impact: Regulatory changes and transparency initiatives can affect pricing stability.
- Price Volatility: Generic drug prices can be volatile, with potential for significant increases.
- Consumer and Payer Impact: Price changes can affect consumer access and healthcare costs.
FAQs
What is Cholestyramine Light used for?
Cholestyramine Light is used to lower cholesterol levels and treat certain types of pruritus associated with liver disease.
Who manufactures Cholestyramine Light?
Cholestyramine Light is manufactured by PuraCap Laboratories LLC, operating under the name Blu Pharmaceuticals.
What is the NDC for Cholestyramine Light?
The NDC for Cholestyramine Light is 24658-0270.
How do regulatory changes affect drug pricing?
Regulatory changes, such as increased transparency and potential upper payment limits, can stabilize or reduce price increases for generic drugs.
What factors influence the pricing of generic drugs like Cholestyramine Light?
Pricing is influenced by production costs, market competition, regulatory oversight, and overall market dynamics.
Sources
- DailyMed: DOXYCYCLINE HYCLATE tablet - DailyMed
- Oregon Drug Price Transparency Program: Prescription Drug Price Transparency Results and Recommendations
- Find-A-Code: Blu Pharmaceuticals, LLC - List of Drugs - NDC Labeler/Manufacturer
- FDA: Proposed Rule on Revising the National Drug Code Format
- FDA: National Drug Code Directory
